rs146220228

Variant summary

Our verdict is Benign. The variant received -11 ACMG points: 2P and 13B. PM1BP4_StrongBP6BS1BS2

The NM_000377.3(WAS):​c.391G>A​(p.Glu131Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00265 in 1,180,777 control chromosomes in the GnomAD database, including 5 homozygotes. There are 978 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0022 ( 1 hom., 77 hem., cov: 23)
Exomes 𝑓: 0.0027 ( 4 hom. 901 hem. )

Consequence

WAS
NM_000377.3 missense

Scores

5
8
3

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:8O:1

Conservation

PhyloP100: 1.61

Publications

10 publications found
Variant links:
Genes affected
WAS (HGNC:12731): (WASP actin nucleation promoting factor) The Wiskott-Aldrich syndrome (WAS) family of proteins share similar domain structure, and are involved in transduction of signals from receptors on the cell surface to the actin cytoskeleton. The presence of a number of different motifs suggests that they are regulated by a number of different stimuli, and interact with multiple proteins. Recent studies have demonstrated that these proteins, directly or indirectly, associate with the small GTPase, Cdc42, known to regulate formation of actin filaments, and the cytoskeletal organizing complex, Arp2/3. Wiskott-Aldrich syndrome is a rare, inherited, X-linked, recessive disease characterized by immune dysregulation and microthrombocytopenia, and is caused by mutations in the WAS gene. The WAS gene product is a cytoplasmic protein, expressed exclusively in hematopoietic cells, which show signalling and cytoskeletal abnormalities in WAS patients. A transcript variant arising as a result of alternative promoter usage, and containing a different 5' UTR sequence, has been described, however, its full-length nature is not known. [provided by RefSeq, Jul 2008]
WAS Gene-Disease associations (from GenCC):
  • Wiskott-Aldrich syndrome
    Inheritance: XL, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet
  • X-linked severe congenital neutropenia
    Inheritance: XL Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
  • thrombocytopenia 1
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -11 ACMG points.

PM1
In a hotspot region, there are 9 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 1 benign, 6 uncertain in NM_000377.3
BP4
Computational evidence support a benign effect (MetaRNN=0.0077780485).
BP6
Variant X-48685764-G-A is Benign according to our data. Variant chrX-48685764-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 135413.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00217 (244/112368) while in subpopulation NFE AF = 0.00336 (179/53264). AF 95% confidence interval is 0.00296. There are 1 homozygotes in GnomAd4. There are 77 alleles in the male GnomAd4 subpopulation. Median coverage is 23. This position passed quality control check.
BS2
High AC in GnomAd4 at 244 XL,AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
WASNM_000377.3 linkc.391G>A p.Glu131Lys missense_variant Exon 4 of 12 ENST00000376701.5 NP_000368.1 P42768A0A024QYX8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
WASENST00000376701.5 linkc.391G>A p.Glu131Lys missense_variant Exon 4 of 12 1 NM_000377.3 ENSP00000365891.4 P42768

Frequencies

GnomAD3 genomes
AF:
0.00216
AC:
243
AN:
112317
Hom.:
1
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.000291
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000942
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00146
Gnomad FIN
AF:
0.00619
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00336
Gnomad OTH
AF:
0.00199
GnomAD2 exomes
AF:
0.00259
AC:
344
AN:
132777
AF XY:
0.00222
show subpopulations
Gnomad AFR exome
AF:
0.000226
Gnomad AMR exome
AF:
0.000456
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00639
Gnomad NFE exome
AF:
0.00384
Gnomad OTH exome
AF:
0.00247
GnomAD4 exome
AF:
0.00270
AC:
2883
AN:
1068409
Hom.:
4
Cov.:
33
AF XY:
0.00259
AC XY:
901
AN XY:
348391
show subpopulations
African (AFR)
AF:
0.000196
AC:
5
AN:
25493
American (AMR)
AF:
0.000427
AC:
13
AN:
30455
Ashkenazi Jewish (ASJ)
AF:
0.0000529
AC:
1
AN:
18921
East Asian (EAS)
AF:
0.00
AC:
0
AN:
28312
South Asian (SAS)
AF:
0.00268
AC:
137
AN:
51094
European-Finnish (FIN)
AF:
0.00584
AC:
225
AN:
38553
Middle Eastern (MID)
AF:
0.00414
AC:
17
AN:
4110
European-Non Finnish (NFE)
AF:
0.00288
AC:
2377
AN:
826520
Other (OTH)
AF:
0.00240
AC:
108
AN:
44951
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
140
281
421
562
702
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
84
168
252
336
420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00217
AC:
244
AN:
112368
Hom.:
1
Cov.:
23
AF XY:
0.00223
AC XY:
77
AN XY:
34518
show subpopulations
African (AFR)
AF:
0.000291
AC:
9
AN:
30963
American (AMR)
AF:
0.000941
AC:
10
AN:
10625
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2652
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3569
South Asian (SAS)
AF:
0.00146
AC:
4
AN:
2733
European-Finnish (FIN)
AF:
0.00619
AC:
38
AN:
6136
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
219
European-Non Finnish (NFE)
AF:
0.00336
AC:
179
AN:
53264
Other (OTH)
AF:
0.00262
AC:
4
AN:
1525
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
9
17
26
34
43
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00248
Hom.:
113
Bravo
AF:
0.00164
TwinsUK
AF:
0.00378
AC:
14
ALSPAC
AF:
0.00312
AC:
9
ESP6500AA
AF:
0.000261
AC:
1
ESP6500EA
AF:
0.00343
AC:
23
ExAC
AF:
0.00254
AC:
296

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:8Other:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:3
May 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

WAS: BS1, BS2 -

Jun 26, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 06, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 32185379, 28008999, 27153395, 8528199, 24728327, 19817875) -

Wiskott-Aldrich syndrome;C1839163:Thrombocytopenia 1;C1845987:X-linked severe congenital neutropenia Benign:2
Apr 13, 2022
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Thrombocytopenia 1 Uncertain:1
-
ISTH-SSC Genomics in Thrombosis and Hemostasis, KU Leuven, Center for Molecular and Vascular Biology
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

X-linked severe congenital neutropenia Benign:1
May 28, 2019
Mendelics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

WAS-related disorder Benign:1
May 06, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Wiskott-Aldrich syndrome Benign:1
Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Other:1
Sep 19, 2013
ITMI
Significance:not provided
Review Status:no classification provided
Collection Method:reference population

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.083
BayesDel_addAF
Pathogenic
0.29
D
BayesDel_noAF
Pathogenic
0.65
CADD
Benign
23
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.79
D;D
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Uncertain
0.97
D;D
MetaRNN
Benign
0.0078
T;T
MetaSVM
Pathogenic
1.1
D
MutationAssessor
Uncertain
2.9
.;M
PhyloP100
1.6
PrimateAI
Uncertain
0.62
T
PROVEAN
Uncertain
-3.4
D;D
REVEL
Pathogenic
0.84
Sift
Uncertain
0.0050
D;D
Sift4G
Uncertain
0.028
D;D
Polyphen
1.0
.;D
Vest4
0.065
MVP
1.0
MPC
1.6
ClinPred
0.033
T
GERP RS
4.3
Varity_R
0.56
gMVP
0.91
Mutation Taster
=68/32
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.060
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs146220228; hg19: chrX-48544153; API